TD Cowen Sticks to Its Buy Rating for Iovance Biotherapeutics (IOVA)
In a report released today, Tyler Van Buren from TD Cowen maintained a Buy rating on Iovance Biotherapeutics (IOVA – Research Report).
CyberArk Software (CYBR) Receives a Buy from Scotiabank
In a report released today, Patrick Colville from Scotiabank reiterated a Buy rating on CyberArk Software (CYBR – Research Report), with ...